<VariationArchive VariationID="13847" VariationName="NM_000222.3(KIT):c.1925_1926del (p.Lys642fs)" VariationType="Deletion" Accession="VCV000013847" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2022-06-05" MostRecentSubmission="2022-06-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="28886" VariationID="13847">
      <GeneList>
        <Gene Symbol="KIT" FullName="KIT proto-oncogene, receptor tyrosine kinase" GeneID="3815" HGNC_ID="HGNC:6342" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="54657957" stop="54740715" display_start="54657957" display_stop="54740715" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="55524094" stop="55606880" display_start="55524094" display_stop="55606880" Strand="+" />
          </Location>
          <OMIM>164920</OMIM>
          <Haploinsufficiency last_evaluated="2024-05-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KIT">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2024-05-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KIT">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000222.3(KIT):c.1925_1926del (p.Lys642fs)</Name>
      <CanonicalSPDI>NC_000004.12:54728054:AAA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="54728055" stop="54728056" display_start="54728055" display_stop="54728056" variantLength="2" positionVCF="54728054" referenceAlleleVCF="CAA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="55594221" stop="55594222" display_start="55594221" display_stop="55594222" variantLength="2" positionVCF="55594220" referenceAlleleVCF="CAA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K638fs</ProteinChange>
      <ProteinChange>K642fs</ProteinChange>
      <ProteinChange>K639fs</ProteinChange>
      <ProteinChange>K643fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.55594222_55594223del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.55594222_55594223del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.54728056_54728057del" Assembly="GRCh38">
            <Expression>NC_000004.12:g.54728056_54728057del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007456.1" sequenceAccession="NG_007456" sequenceVersion="1" change="g.75062_75063del">
            <Expression>NG_007456.1:g.75062_75063del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000222.3" sequenceAccession="NM_000222" sequenceVersion="3" change="c.1925_1926del" MANESelect="true">
            <Expression>NM_000222.3:c.1925_1926del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000213.1" sequenceAccession="NP_000213" sequenceVersion="1" change="p.Lys642fs">
            <Expression>NP_000213.1:p.Lys642fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001093772.2" sequenceAccession="NM_001093772" sequenceVersion="2" change="c.1913_1914del">
            <Expression>NM_001093772.2:c.1913_1914del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001087241.1" sequenceAccession="NP_001087241" sequenceVersion="1" change="p.Lys638fs">
            <Expression>NP_001087241.1:p.Lys638fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001385284.1" sequenceAccession="NM_001385284" sequenceVersion="1" change="c.1928_1929del">
            <Expression>NM_001385284.1:c.1928_1929del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372213.1" sequenceAccession="NP_001372213" sequenceVersion="1" change="p.Lys643fs">
            <Expression>NP_001372213.1:p.Lys643fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001385285.1" sequenceAccession="NM_001385285" sequenceVersion="1" change="c.1925_1926del">
            <Expression>NM_001385285.1:c.1925_1926del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372214.1" sequenceAccession="NP_001372214" sequenceVersion="1" change="p.Lys642fs">
            <Expression>NP_001372214.1:p.Lys642fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001385286.1" sequenceAccession="NM_001385286" sequenceVersion="1" change="c.1913_1914del">
            <Expression>NM_001385286.1:c.1913_1914del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372215.1" sequenceAccession="NP_001372215" sequenceVersion="1" change="p.Lys638fs">
            <Expression>NP_001372215.1:p.Lys638fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001385288.1" sequenceAccession="NM_001385288" sequenceVersion="1" change="c.1916_1917del">
            <Expression>NM_001385288.1:c.1916_1917del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372217.1" sequenceAccession="NP_001372217" sequenceVersion="1" change="p.Lys639fs">
            <Expression>NP_001372217.1:p.Lys639fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001385290.1" sequenceAccession="NM_001385290" sequenceVersion="1" change="c.1928_1929del">
            <Expression>NM_001385290.1:c.1928_1929del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372219.1" sequenceAccession="NP_001372219" sequenceVersion="1" change="p.Lys643fs">
            <Expression>NP_001372219.1:p.Lys643fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001385292.1" sequenceAccession="NM_001385292" sequenceVersion="1" change="c.1916_1917del">
            <Expression>NM_001385292.1:c.1916_1917del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372221.1" sequenceAccession="NP_001372221" sequenceVersion="1" change="p.Lys639fs">
            <Expression>NP_001372221.1:p.Lys639fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_307" sequenceAccession="LRG_307">
            <Expression>LRG_307:g.75062_75063del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_307t1" sequenceAccession="LRG_307t1">
            <Expression>LRG_307t1:c.1925_1926del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_307p1" sequenceAccession="LRG_307p1" change="p.Lys642fs">
            <Expression>LRG_307p1:p.Lys642fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA123507" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="164920.0004" DB="OMIM" />
        <XRef Type="rs" ID="794726672" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000222.3(KIT):c.1925_1926del (p.Lys642fs) AND Piebaldism" Accession="RCV000014859" Version="26">
        <ClassifiedConditionList TraitSetID="2041">
          <ClassifiedCondition DB="MedGen" ID="C0080024">Piebaldism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1992-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1992-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-06-05" MostRecentSubmission="2022-06-05">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1370874</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2041" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5759" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Piebald skin depigmentation</ElementValue>
                <XRef ID="HP:0007544" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Piebaldism</ElementValue>
                <XRef ID="MONDO:0008244" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBT</ElementValue>
                <XRef Type="MIM" ID="172800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Piebald Trait, SNAI2-Related</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Piebaldism is a rare autosomal dominant trait characterized by the congenital absence of melanocytes in affected areas of the skin and hair. A white forelock of hair, often triangular in shape, may be the only manifestation, or both the hair and the underlying forehead may be involved. The eyebrows and eyelashes may be affected. Irregularly shaped white patches may be observed on the face, trunk, and extremities, usually in a symmetrical distribution. Typically, islands of hyperpigmentation are present within and at the border of depigmented areas (summary by Thomas et al., 2004).</Attribute>
                <XRef Type="MIM" ID="172800" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Piebald Trait, KIT-Related</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4344" />
                <XRef ID="4344" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2884" DB="Orphanet" />
              <XRef ID="C0080024" DB="MedGen" />
              <XRef ID="MONDO:0008244" DB="MONDO" />
              <XRef Type="MIM" ID="172800" DB="OMIM" />
              <XRef Type="primary" ID="HP:0007544" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001044" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="35114" SubmissionDate="2022-06-01" DateLastUpdated="2022-06-05" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="164920.0004_PIEBALDISM" title="KIT, 2-BP DEL, FS647TER_PIEBALDISM" />
        <ClinVarAccession Accession="SCV000035114" DateUpdated="2022-06-05" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1992-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 affected individuals over 3 generations of a Caucasian family with piebaldism (154800), Spritz et al. (1992) identified deletion of 2 bases from the AAA triplet of codon 642 within exon 13 in the tyrosine kinase domain. This resulted in a frameshift distal to codon 641, terminating only 6 residues downstream at a novel in-frame TAA. The proband and other members of the family had no dysmorphia or heterochromia iridis, and hearing was normal. However, the proband reported chronic severe constipation.</Attribute>
              <Citation>
                <ID Source="PubMed">1370874</ID>
              </Citation>
              <XRef DB="OMIM" ID="154800" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KIT" />
          </GeneList>
          <Name>KIT, 2-BP DEL, FS647TER</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, FS647TER</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="164920.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PIEBALDISM</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="35114" TraitType="Disease" MappingType="Name" MappingValue="PIEBALDISM" MappingRef="Preferred">
        <MedGen CUI="C0080024" Name="Piebaldism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

